Machine signal
Active cluster sell — 3 distinct insiders, $5.1K, window ends Sep 8, 2026.
Figures computed from official regulatory filings — .
Analysttarget 7 USD (+573%)
Ownershipinsiders 19.02% · institutions 18.72% · short 4.7% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Metagenomi Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
4 buys26 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Reid Laurence | Buy | $138.1 | conv 54First in 12mo |
| SEC |
| Reid Laurence | Buy | $23.3K | conv 78First in 12mo | SEC |
| Irish Jian | Sell | $2.5K | SEC |
| Wapnick Pamela | Sell | $2.2K | SEC |
| Wein Matthew | Sell | $414.7 | SEC |
| BJERKHOLT ERICtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Eckhardt Juergen | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dere Willard H | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Reid Laurence | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Irish Jian | Sell | $4.9K | SEC |
| Wein Matthew | Sell | $724.8 | SEC |
| Wapnick Pamela | Sell | $3.7K | SEC |
| Wapnick Pamela | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wein Matthew | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wapnick Pamela | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Irish Jian | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Irish Jian | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wein Matthew | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wein Matthew | Sell | $771.2 | SEC |
| Irish Jian | Sell | $2.6K | SEC |
| Wapnick Pamela | Sell | $2.5K | SEC |
| Irish Jian | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wein Matthew | Sell | $352.2 | SEC |
| Wapnick Pamela | Sell | $2.8K | SEC |
| Irish Jian | Sell | $2.8K | SEC |